Ulla Hald Buhl

Directeur des opérations chez CHOSA ONCOLOGY AB

Profil

Ulla Hald Buhl was the founder and the Chief Operating Officer & Director of Oncology Venture Sweden AB, which was founded in 2012.
Ms. Buhl is also the founder of Buhl Oncology ApS, Buhl Krone Holding ApS, and Aïda Oncology ApS.
Currently, Ms. Buhl holds the position of Chief Operating Officer & Director at Chosa Oncology AB since 2022.
Previously, Ms. Buhl served as the Chairman of Cessatech A from 2020 to 2021.
From 2001 to 2010, Ms. Buhl worked as the Director of Investor Relations & Communications at Topotarget A. Ms. Buhl also held the position of COO, Director & Head of Communication at Allarity Therapeutics Europe ApS from 2012 to 2019.
Additionally, Ms. Buhl served as a Director at Oncology Venture US, Inc. from 2016 to 2019.
From 2010 to 2016, Ms. Buhl worked as the Chief Clinical Operations at Wntresearch AB and Liplasome Pharma ApS.
Ms. Buhl also served as the Chief Investor Relations & Communications Officer at Medical Prognosis Institute.
A. Furthermore, Ms. Buhl held the position of Chief Operating Officer at Allarity Therapeutics A from 2012 to 2019.
Ms. Buhl completed an undergraduate degree at the University of Southern Denmark.
Ms. Buhl is also the founder of Buhl Oncology ApS, Buhl Krone Holding ApS, Aïda Oncology ApS.

Postes actifs de Ulla Hald Buhl

Sociétés	Poste	Début
CHOSA ONCOLOGY AB	Directeur des opérations	01/03/2022
Buhl Krone Holding ApS	Directeur Général	-

Anciens postes connus de Ulla Hald Buhl

Sociétés	Poste	Fin
CESSATECH A/S	Président	01/07/2021
Allarity Therapeutics Europe ApS	Directeur des opérations	01/10/2019
Allarity Therapeutics A/S	Directeur des opérations	01/10/2019
Oncology Venture US, Inc.	Directeur/Membre du Conseil	01/10/2019
WNTRESEARCH AB	Corporate Officer/Principal	01/01/2016